Journal
JOURNAL OF BIOCHEMISTRY
Volume 132, Issue 6, Pages 853-857Publisher
OXFORD UNIV PRESS
DOI: 10.1093/oxfordjournals.jbchem.a003297
Keywords
B-lymphocytes; cell cycle control; cell differentiation; cholesterol sulfate; squamous epithelia
Categories
Ask authors/readers for more resources
The eta isoform of protein kinase C (PKCeta) is classified into the Ca2+-independent novel PKC subfamily and assigned to human chromosome 14 (14q22-23) and mouse chromosome 12 (12C3-D2). It is highly expressed in epithelial tissues especially in squamous epithelia. PKCeta is unique in that it is specifically activated by cholesterol sulfate and sulfatide, sulfated metabolites of cholesterol and cerebroside, respectively. PKCeta overexpression induces G1 arrest and differentiation in keratinocytes. PKCeta-induced differentiation is accompanied by the transcriptional activation of transglutaminase 1, a key enzyme in squamous differentiation, and involucrin, a precursor of cornified envelopes. In keratinocytes, PKCeta associates with the cyclin E/cdk2/p21 complex and inhibits the cdk2-kinase activity, leading to G1 arrest. Cholesterol sulfate inhibits the promotional phase of skin carcinogenesis. Moreover, PKCeta-knockout mice show a much higher sensitivity to carcinogenesis, suggesting that PKCeta is negatively involved in tumor promotion through stimulation of keratinocyte differentiation. In addition to epithelial cells, recent studies revealed that PKCeta acts as a key regulator in early B-cell development. Although the functions of PKCeta in other cell types are not yet fully elucidated, available evidence indicates that this particular isoform plays crucial roles in the signaling of cell differentiation in a cell-type-specific manner.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available